[
  {
    "ts": null,
    "headline": "Tracking Christopher Davis' Davis Selected Advisers 13F Portfolio - Q1 2025 Update",
    "summary": "Davis Selected Advisersâ 13F portfolio value increased to $17.35B, with the number of holdings rising from 100 to 104. Learn more about the portfolio here.",
    "url": "https://finnhub.io/api/news?id=ad893fda7efff23edddd51ef47b42c28e4a61952dee0627cf6e215442dd95b5d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747166969,
      "headline": "Tracking Christopher Davis' Davis Selected Advisers 13F Portfolio - Q1 2025 Update",
      "id": 134425396,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1200139358/image_1200139358.jpg?io=getty-c-w1536",
      "related": "HUM",
      "source": "SeekingAlpha",
      "summary": "Davis Selected Advisersâ 13F portfolio value increased to $17.35B, with the number of holdings rising from 100 to 104. Learn more about the portfolio here.",
      "url": "https://finnhub.io/api/news?id=ad893fda7efff23edddd51ef47b42c28e4a61952dee0627cf6e215442dd95b5d"
    }
  },
  {
    "ts": null,
    "headline": "UnitedHealth’s troubles get worse, as 2025 outlook suspended and CEO steps down",
    "summary": "UnitedHealth’s troubles get worse, as 2025 outlook suspended and CEO steps down",
    "url": "https://finnhub.io/api/news?id=55d02d8f407c0bcd818eb41d83bbd09b84778367458e590a84a6de9b5944c597",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747135440,
      "headline": "UnitedHealth’s troubles get worse, as 2025 outlook suspended and CEO steps down",
      "id": 134402308,
      "image": "",
      "related": "HUM",
      "source": "MarketWatch",
      "summary": "UnitedHealth’s troubles get worse, as 2025 outlook suspended and CEO steps down",
      "url": "https://finnhub.io/api/news?id=55d02d8f407c0bcd818eb41d83bbd09b84778367458e590a84a6de9b5944c597"
    }
  },
  {
    "ts": null,
    "headline": "UnitedHealth Suspends Outlook, CEO Steps Down. Yes, It Can Get Worse.",
    "summary": "UnitedHealth Suspends Outlook, CEO Steps Down. Yes, It Can Get Worse.",
    "url": "https://finnhub.io/api/news?id=dcd76ad1652ba0effe07f2bad8e0170e212b7930a1bbca78fcfcf90f73375bee",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747129740,
      "headline": "UnitedHealth Suspends Outlook, CEO Steps Down. Yes, It Can Get Worse.",
      "id": 134402310,
      "image": "",
      "related": "HUM",
      "source": "MarketWatch",
      "summary": "UnitedHealth Suspends Outlook, CEO Steps Down. Yes, It Can Get Worse.",
      "url": "https://finnhub.io/api/news?id=dcd76ad1652ba0effe07f2bad8e0170e212b7930a1bbca78fcfcf90f73375bee"
    }
  },
  {
    "ts": null,
    "headline": "HUM Q1 Earnings Call: Management Highlights Margin Expansion and Strategic Shifts Amid Industry Uncertainty",
    "summary": "Health insurance company Humana (NYSE:HUM) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 8.4% year on year to $32.11 billion. The company’s full-year revenue guidance of $127 billion at the midpoint came in 0.7% above analysts’ estimates. Its non-GAAP profit of $11.58 per share was 15% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=61dd052613bf904592ab96257d1d5aec8ef963f545667f65f1416bf02c90aed4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747143392,
      "headline": "HUM Q1 Earnings Call: Management Highlights Margin Expansion and Strategic Shifts Amid Industry Uncertainty",
      "id": 134409871,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HUM",
      "source": "Yahoo",
      "summary": "Health insurance company Humana (NYSE:HUM) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 8.4% year on year to $32.11 billion. The company’s full-year revenue guidance of $127 billion at the midpoint came in 0.7% above analysts’ estimates. Its non-GAAP profit of $11.58 per share was 15% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=61dd052613bf904592ab96257d1d5aec8ef963f545667f65f1416bf02c90aed4"
    }
  },
  {
    "ts": null,
    "headline": "CenterWell Specialty Pharmacy Takes National Patient Choice Award",
    "summary": "LOUISVILLE, Ky., May 13, 2025--CenterWell Specialty Pharmacy takes national Patient Choice Award.",
    "url": "https://finnhub.io/api/news?id=4c32cdbf85f1834392dd62433c55f549d56791312ed427e67070441f0f624f10",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747141200,
      "headline": "CenterWell Specialty Pharmacy Takes National Patient Choice Award",
      "id": 134409872,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HUM",
      "source": "Yahoo",
      "summary": "LOUISVILLE, Ky., May 13, 2025--CenterWell Specialty Pharmacy takes national Patient Choice Award.",
      "url": "https://finnhub.io/api/news?id=4c32cdbf85f1834392dd62433c55f549d56791312ed427e67070441f0f624f10"
    }
  },
  {
    "ts": null,
    "headline": "UnitedHealth Group Is In Chaos",
    "summary": "UnitedHealth Group Incorporated stock drops after a rare earnings miss and CEO resignation. Click for the impact and potential buying opportunity in UNH at $335.",
    "url": "https://finnhub.io/api/news?id=d0c982b913592455ecd760074a3f74c94d870daf17ad9a3e9b3f4a5721d805ba",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747131677,
      "headline": "UnitedHealth Group Is In Chaos",
      "id": 134399959,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2117487387/image_2117487387.jpg?io=getty-c-w1536",
      "related": "HUM",
      "source": "SeekingAlpha",
      "summary": "UnitedHealth Group Incorporated stock drops after a rare earnings miss and CEO resignation. Click for the impact and potential buying opportunity in UNH at $335.",
      "url": "https://finnhub.io/api/news?id=d0c982b913592455ecd760074a3f74c94d870daf17ad9a3e9b3f4a5721d805ba"
    }
  },
  {
    "ts": null,
    "headline": "UnitedHealth Dives To 4-Year Low On Cost Warning, CEO Exit",
    "summary": "UnitedHealth Dives To 4-Year Low On Cost Warning, CEO Exit",
    "url": "https://finnhub.io/api/news?id=f795aeca1aeaeb8f9da74a50ef82a05537a8f36a77de6c46fe34b91459fb5279",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747130708,
      "headline": "UnitedHealth Dives To 4-Year Low On Cost Warning, CEO Exit",
      "id": 134402287,
      "image": "",
      "related": "HUM",
      "source": "DowJones",
      "summary": "UnitedHealth Dives To 4-Year Low On Cost Warning, CEO Exit",
      "url": "https://finnhub.io/api/news?id=f795aeca1aeaeb8f9da74a50ef82a05537a8f36a77de6c46fe34b91459fb5279"
    }
  }
]